• • What is the Stent Save A Live Initiative?

  • The Stent Save A Live Initiative is a unique European platform for interventional cardiologists, government representatives, industry partners, advocacy groups and patients to work together and, by shaping the healthcare systems and medical practices, ensure that the majority of ST elevated myocardial infarction (STEMI) patients will have an equal access to the life saving indication of primary percutaneous coronary intervention (p-PCI).

  •  

• • Which countries are involved in the Stent Save A Live Initiative?

  • There are currently twelve countries involved in the Stent Save A Live Initiative: Bulgaria, France, Greece, Serbia, Spain, Turkey (all since 2009), Egypt, Italy, Romania (since 2010), Portugal (2011), Ukraine, Bosnia and Herzegovina

  •  

• • What is the overall aim of the Stent Save A Live Initiative?

    The overall aim of the Stent Save A Live Initiative is to improve the delivery and patient access to the life-saving indications of p-PCI, thereby reducing the mortality and morbidity of patients suffering from acute coronary syndromes (ACS).

  •  

What are the objectives of the Stent Save A Live Initiative?
There are two key objectives to be achieved that will determine the success of the Stent Save A Live Initiative: Define regions and countries with an unmet medical need in the optimal treatment of ACS In the regions/countries, implement an action program to increase patient access to p-PCI where indicated:
1) To increase the use of p-PCI to more than 70% among all STEMI patients.
2) To achieve PCI rates of more than 600 per one million inhabitants per year.
3) To offer 24/7 service for p-PCI procedures at invasive facilities to cover the country STEMI population need.

• • How does the Stent Save A Live Initiative aim to achieve its objectives?

    The Stent Save A Live Initiative is supported by National Cardiac Societies in ten European countries. Each of the countries will work to implement local STEMI treatment guidelines, help identify specific barriers to implementation of guidelines, and define actions needed to ensure that the majority of STEMI patients have access to the life saving indication of p-PCI.

  •  

• • Why is an initiative like Stent Save A Live needed?

    Patient access to p-PCI varies considerably between European countries (from around 5% to 92%).1 The lack of organised p-PCI networks is associated with fewer patients overall receiving some form of reperfusion therapy, and with sub-optimal outcomes. Primary PCI rates of more than 600 per million are needed to provide this treatment for most STEMI patients in Europe.1

  •  

• • Who is involved in the Stent Save A Live Initiative?

    Ensuring access to p-PCI involves the combined support and participation of many stakeholders and partners, including interventional cardiologists, government representatives, industry (such as pharmaceuticals, automotive, telecom, etc), advocacy groups and patients themselves. What is the role of the industry partners (both at a European and local level) in supporting the Stent Save A Live Initiative? The industry partners sign up to be a part of the Stent Save A Live Initiative because they are willing to actively support the project goals. This support may include participating in defining strategy, as well as providing expertise such as project management, local analysis, patient awareness, promotion, funding and investment planning. They do not however, under any circumstances, influence the scientific content of the Initiative.

  •  

• What is the role of the industry partners (both at a European and local level) in supporting the Stent Save A Live Initiative?

  The industry partners sign up to be a part of the Stent Save A Live Initiative because they are willing to actively support the project goals. This support may include participating in defining strategy, as well as providing expertise such as project management, local analysis, patient awareness, promotion, funding and investment planning. They do not however, under any circumstances, influence the scientific content of the Initiative.